Headway in Alzheimer’s Disease Care: New Guidance Provides Recommendations for Use of Anti-Amyloid Monoclonal Antibodies

BASEL, SWITZERLAND, April 24, 2025 /EINPresswire.com/ -- The new guidelines for the use of monoclonal antibodies (mAbs) published in Neurodegenerative Diseases, serve as exemplary clinical recommendations for clinicians and healthcare…

Continue ReadingHeadway in Alzheimer’s Disease Care: New Guidance Provides Recommendations for Use of Anti-Amyloid Monoclonal Antibodies

Dementia

Things that increase the risk of developing dementia include: age (more common in those 65 or older) high blood pressure (hypertension) high blood sugar (diabetes) being overweight or obese smoking…

Continue ReadingDementia